NCT01558284View on ClinicalTrials.gov

The Effect of Neu-P11 on Symptoms in Patients With D-IBS

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

February 28, 2014

Conditions
Diarrhea- Irritable Bowel Syndrome
Interventions
DRUG

Neu-P11

Neu-P11 is a new Melatonin receptor-, Serotonin 5-HT- 1A and 5-HT- 1D - agonist and a serotonin 5-HT- 2B - antagonist

DRUG

Placebo

Placebo

Trial Locations (1)

81377

Klinikum Grosshadern Medizinische Klinik 2, Munich

All Listed Sponsors
lead

Ludwig-Maximilians - University of Munich

OTHER

NCT01558284 - The Effect of Neu-P11 on Symptoms in Patients With D-IBS | Biotech Hunter | Biotech Hunter